Capital Flow

Capital FlowFinTech & Future Assets

Raytheon Delivers First NGJ-MB Jammer Pods to the RAAF, as EA-18G Growler Enters a New Phase of Electronic Warfare Capability Upgrades

Three independent sources consistently confirm that Raytheon (RTX/Raytheon) has delivered the first AN/ALQ-249 Next Generation Jammer Mid-Band (NGJ-MB) jamming pods/shipsets to the Royal Australian Air Force (RAAF) for the EA-18G Growler. The sources collectively indicate that the first deliveries took place in September 2025, with further deliveries continuing through 2026; some of the information comes from Raytheon’s remarks on April 20, 2026. The sources do not provide verifiable details on delivery quantities, follow-on procurement scale, or sustainment arrangements.

Apr 21, 2026

Capital FlowSector Deep-dive

Japanese agritech startup Culta raises $4.5 million in pre-Series A funding, focusing on an AI non-GMO breeding platform

Japanese agritech startup Culta has secured 7 million yen, or about $4.5 million, in pre-Series A funding to expand its AI-driven non-GMO crop breeding platform. All three sources confirm the funding amount and company name; one source says its core innovation is cutting the breeding cycle from more than 10 years to about two years. The provided sources do not mention investors, round structure details, or broader business metrics.

Capital FlowFinTech & Future Assets

Novidea Shortlisted for PropertyCasualty360 Insurance Luminaries 2026 Award in the “Product or Service Innovation” Category

On April 14, 2026, Novidea announced that it had been shortlisted for the “Product or Service Innovation” category of the 2026 PropertyCasualty360 Insurance Luminaries Awards. All three sources agree that the winner will be announced at the awards dinner on June 24, 2026, at The Palmer House in Chicago. Beyond the shortlist status and announcement timing, the sources provide no additional background information.

Capital FlowCorporate Strategy

J.P. Morgan’s Q1 Biopharma Venture Report: Early-Stage Funding Slows as Capital Concentrates in Later-Stage and Larger Deals

J.P. Morgan’s Q1 2026 biopharma venture report shows that seed and Series A financing cooled noticeably, while funding at Series B and beyond remained relatively active. At the same time, three sources point to a consistent view: capital is flowing more heavily into more mature, lower-risk projects, and the IPO and M&A windows are recovering unevenly. However, some sources do not provide enough information on the underlying causes, the full industry picture, or the subsequent trend.

Capital FlowMacro Insights

After Safe-Haven Buying Fades in the U.S.-Iran Conflict, the Dollar Gives Back Most of Its Gains as Markets Still Assess the “Geopolitical Risk Premium”

According to three Reuters reports, the dollar index surged on safe-haven demand after the U.S.-Iran conflict broke out, then gave back most of those gains as ceasefire expectations and hopes for a new round of Iran talks intensified. All three sources point to the same main line: the dollar, boosted earlier by geopolitical tensions, has clearly lost part of its war premium; but on whether it will weaken further, the sources only show that markets are still assessing the situation and do not offer a unified conclusion.